EUVIMEDEUVIMED entdecken
Open Access

MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer

Sung-Hsin Kuo iD, Ming-Feng Wei, Yi-Hsuan Lee, Jui-Chueh Lin, Wen-Chi Yang, Shi-Yi Yang, Chiun-Sheng Huang

Cellular Oncology · 2023-10 · 46 (5) · 1213-1234

DOI: 10.1007/s13402-023-00805-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 11.05.2023. Verfasst von Sung-Hsin Kuo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Oncology, National Taiwan University Hospital , Taipei, Taiwan. Hauptthemen laut MEDLINE: Breast Neoplasms, MAP Kinase Kinase Kinase 1. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Science and Technology, Taiwan, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMAP Kinase Kinase Kinase 1HumansAnimalsMiceFemaleNF-kappa BErb-b2 Receptor Tyrosine KinasesTamoxifenDisease-Free Survivalp38 Mitogen-Activated Protein Kinases

Stichwörter der Autor:innen

Breast CancerHormone receptor-positiveMAP3K1NF-κBPrognosis

Substanzen

NF-kappa BErb-b2 Receptor Tyrosine KinasesTamoxifenp38 Mitogen-Activated Protein KinasesMAP Kinase Kinase Kinase 1MAP3K1 protein, human

Autor:innen und Institutionen

  • Departments of Oncology, National Taiwan University Hospital , Taipei, Taiwan.
  • Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Cancer Research Center, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Departments of Pathology, National Taiwan University Hospital, and College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Department of Surgery, National Taiwan University Hospital, and College of Medicine, National Taiwan University, No. 7, Chung-Shan South Rd, Taipei, Taiwan.
  • Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan.

ORCID-Profile: Sung-Hsin Kuo

Förderung

  • Ministry of Science and Technology, Taiwan
  • Ministry of Health and Welfare

Zitieren

APA

Kuo, S. H., Wei, M. F., Lee, Y. H., Lin, J. C., Yang, W. C., Yang, S. Y., & Huang, C. S. (2023). MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer. Cellular Oncology, 46(5), 1213-1234. https://doi.org/10.1007/s13402-023-00805-w

Vancouver

Kuo SH, Wei MF, Lee YH, Lin JC, Yang WC, Yang SY, et al. MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer. Cellular Oncology. 2023;46(5):1213-1234. doi:10.1007/s13402-023-00805-w

BibTeX
@article{Kuo2023,
  author = {Kuo, Sung-Hsin and Wei, Ming-Feng and Lee, Yi-Hsuan and Lin, Jui-Chueh and Yang, Wen-Chi and Yang, Shi-Yi and Huang, Chiun-Sheng},
  title = {MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer},
  journal = {Cellular Oncology},
  year = {2023},
  volume = {46},
  number = {5},
  pages = {1213--1234},
  doi = {10.1007/s13402-023-00805-w}
}
Kostenlos starten →